PMID: 2501063Mar 1, 1989Paper

Anticardiolipin antibodies in patients with infectious diseases

Clinical Rheumatology
M B SantiagoR M Oliveira

Abstract

IgG or IgM anticardiolipin antibodies were present in the sera of 67% of 33 patients with Hansen's disease, in 53% of 30 patients with tuberculosis and in 50% of 16 patients with endocarditis. Despite the high frequency of these antibodies, no patient had a history of thrombosis or abortion. Anti-denatured DNA antibodies were tested in patients with tuberculosis and patients with Hansen's disease. Only in the latter group did we observe a statistically significant association between anticardiolipin and anti-denatured DNA antibodies. Anticardiolipin binding activity, however, could not be inhibited by preincubation of sera with a variable concentration of denatured DNA. These data suggest that: a) Anticardiolipin antibodies in infectious diseases do not necessarily participate in the pathogenesis of thrombotic or obstetric complications; b) Anti-denatured DNA and anticardiolipin antibodies in the population studied do not have a cross-reaction.

References

Feb 1, 1985·The Journal of Clinical Investigation·R S Schwartz, B D Stollar
Oct 1, 1986·Clinical Immunology and Immunopathology·O VaaralaK Aho
Jan 1, 1987·Annals of the Rheumatic Diseases·A E GharaviG R Hughes
Dec 1, 1985·Annals of the Rheumatic Diseases·R A AshersonG R Hughes
Sep 15, 1984·British Medical Journal·J G ThorntonL A Tovey

❮ Previous
Next ❯

Citations

Jan 16, 2007·Internal and Emergency Medicine·Annalisa BerzigottiMarco Zoli
Mar 3, 2007·Clinical Rheumatology·Liliana GalrãoMittermayer Santiago
Nov 1, 1993·Pediatric Neurology·V RumiC Besana
May 3, 2008·Nature Protocols·Silvia S Pierangeli, Eon Nigel Harris
Mar 21, 1998·Journal of Gastroenterology and Hepatology·H J LeeJ C Chang
Mar 1, 1991·Clinical Rheumatology·J SabbagaR M De Oliveira
Apr 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C QueredaJ Ortuño
Nov 14, 2003·Journal of Clinical Laboratory Analysis·Iván PalomoSilvia Pierangeli
Jul 22, 2006·Journal of Thrombosis and Haemostasis : JTH·R BuddS S Pierangeli
Feb 1, 1995·Baillière's Clinical Rheumatology·A O Adebajo, D A Isenberg
Apr 8, 2000·Blood Cells, Molecules & Diseases·J A FernándezJ H Griffin
Jan 11, 2013·Memórias do Instituto Oswaldo Cruz·Isabel BaezaIris Estrada-Garcia
May 16, 2006·Revista Do Instituto De Medicina Tropical De São Paulo·Juan José Cortez-EscalanteMuhammad Wasif Saif
Jun 11, 2004·Nephrology·Kuddusi CengizAbdulkerim Bedir
Sep 9, 2006·Journal of Clinical Laboratory Analysis·Iván PalomoRicardo Forastiero
May 3, 2007·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Rahul NaithaniVed P Choudhary
Apr 1, 1991·Annals of the Rheumatic Diseases·M B SantiagoW Cossermelli
Jul 1, 1995·São Paulo Medical Journal = Revista Paulista De Medicina·W Cossermelli-Messina, W Cossermelli
Jan 7, 2018·Heart·Christine Selton-SutyUNKNOWN Endocarditis Team of the University Hospital of Nancy, France
May 11, 2002·Anaesthesia and Intensive Care·R Nagappan, R S Lodge
Apr 1, 1993·Clinical and Experimental Immunology·A O AdebajoB L Hazleman
Mar 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karsten FischerUlrich E Schaible
Oct 6, 2017·Frontiers in Cardiovascular Medicine·Rayan Jo RachwanRachoin Rachoin
Nov 30, 2019·Advances in Rheumatology·Sandra Lúcia Euzébio RibeiroMaria Cristina Dos-Santos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.